Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Citrate therapy in treating urate nephrolithiasis].

N F Sergienko, L V Shaplygin, S F Kuchits

    Urologiia I Nefrologiia
    |November 19, 2002
    PubMed
    Summary

    Citrate therapy effectively treats urate nephrolithiasis in many patients, whether used alone or with other treatments. Blemaren is recommended as a highly beneficial citrate drug for managing kidney stones.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [CLASSICAL RADICAL EXTRAURETHRAL METHOD OF ADENOMECTOMY--BEYOND 30 YEARS].

    Urologiia (Moscow, Russia : 1999)·2015
    Same author

    [Comparative characteristics of the results of current surgical treatments in patients with prostate adenoma].

    Urologiia (Moscow, Russia : 1999)·2014
    Same author

    [High-technology extraurethral adenomectomy].

    Urologiia (Moscow, Russia : 1999)·2013
    Same author

    [Retropubic urethro- and vessel-preserving extraurethral adenomectomy].

    Urologiia (Moscow, Russia : 1999)·2013
    Same author

    [On the question of the so-called gold standard of surgical treatment of benign prostatic hyperplasia].

    Urologiia (Moscow, Russia : 1999)·2012
    Same author

    [Iliac neobladder - 10-year experience].

    Urologiia (Moscow, Russia : 1999)·2012

    Area of Science:

    • Nephrology
    • Urology
    • Pharmacology

    Context:

    • Urate nephrolithiasis is a common condition requiring effective treatment.
    • Current treatment strategies include invasive and remote interventions.
    • Citrate therapy offers a potential non-invasive approach.

    Purpose:

    • To evaluate the efficacy of citrate therapy in patients with urate nephrolithiasis.
    • To compare the effectiveness of citrate monotherapy versus combination therapy.
    • To identify the most beneficial citrate drug for managing urate stones.

    Summary:

    • Citrate therapy was administered to 483 patients diagnosed with urate nephrolithiasis.
    • A positive therapeutic response was observed in patients receiving citrate as monotherapy.
    • Combination therapy involving citrate with invasive or remote treatments also yielded good results.
    • The drug Blemaren (ESPARMA, Germany) was identified as the most advantageous among the evaluated citrate medications.

    Impact:

    • Citrate therapy presents a viable and effective treatment option for urate nephrolithiasis.
    • The findings support the use of Blemaren as a preferred citrate agent.
    • This research may influence clinical guidelines for managing urate kidney stones.

    Related Experiment Videos